In line with our results, hsa-miR-574-5p was found to be downregulated in stroke patients and has been proposed as a biomarker for stroke diagnosis [17], while single nucleotide polymorphisms (SNPs) in one of its targets, FOXI2, has been identified as a risk factor for large vessel ischemic stroke [18]. Here, FOXI2 is linked to stroke disorder.